Want to watch our Cannabis Capital Conference live? For existing subscribers, you can get direct access. For new users, you can get instant access here
Save time and jump to the most important pieces.
4 - Gold Flora Corp. (0001876945) (Issuer)
4 - Gold Flora Corp. (0001876945) (Issuer)
4 - Gold Flora Corp. (0001876945) (Issuer)
Reports $32.6 Million in Q3 2024 Revenue and Adjusted Gross Profit of $21.1 Million, Representing a 65% Adjusted Gross Margin Achieves Positive Adjusted EBITDA of $2.8 Million Recent Cultivation Investments Delivered 20% Improvement in Q3 2024 Flower Harvest Yields Compared to Q1 2024 Conference Call to be Held November 14, 2024, at 6:00 p.m. (Eastern Time) COSTA MESA, Calif., Nov. 14, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (CBOE: GRAM) (OTCQB:GRAM) a leading vertically-integrated California cannabis company, announced its financial results for the three month period ("Q3 2024"). All amounts are expressed in U.S. dollars.
COSTA MESA, Calif., Nov. 6, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB:GRAM) a leading vertically-integrated California cannabis company, today announced it will report financial results for the third quarter ended September 30, 2024, on Thursday, November 14, 2024. The Company will host a conference call to discuss the results on November 14, 2024, at 6:00 p.m. Eastern Time. CONFERENCE CALL DETAILS DATE: Thursday, November 14th, 2024 TIME: 6:00 p.m. Eastern Time WEBCAST: Click Here DIAL-IN NUMBER: 1-800-836-8184 CONFERENCE
Grew Revenue 13% Sequentially to $32.2 Million Achieved Adjusted Gross Profit of $17.4 Million, Representing 54% Adjusted Gross Margin Conference Call to be Held May 15, 2024, at 6:00 p.m. ET COSTA MESA, Calif., May 15, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) a leading vertically-integrated California cannabis company, announced its financial results for the three-month period ("Q1 2024"). All amounts are expressed in U.S. dollars. Q1 2024 Financial Highlights: Total revenue was $32.2 million, representing a 13% sequential grow
The Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance. We broke the 30 MSO/SSOs that Viridian ranks each week into five different groups arranged with the strongest six companies on the left (Group 1) and the weakest six companies on the right (Group 5). Group 1: Green Thumb (OTC:GTBIF), Trulieve (OTC:TCNNF), Grown Rogue (OTC:GRUSF), Verano (OTC:VRNOF), Cresco (OTC:CRLBF) and Planet 13 (OTC:PLNH) Group 2: Curaleaf (OTC:CURLF), Cansortium (OTC:CNTMF) (proforma), C21 (OTC:CXXIF), MariMed (OTC:MRMD), Vext (OTC:VEXTF), and Ascend (OTC:AAWH) Group 3: AYR (OTC:AYRWF), TerrAscend (OTC:TSNDF), 1933 Industries (OTC:TGIFF), Gl
"For us, everything starts with cultivation," Laurie Holcomb founder and CEO of Gold Flora (OTC:GRAM) told the crowd gathered at the recent Benzinga cannabis event –Cannabis Market Spotlight on Monday in New Jersey. "We’ve got 107,000 square feet of canopy. It’s all indoor. So we’re one of the largest indoor cultivators in California.” This seed-to-sale publicly traded cannabis company is the third in terms of retail footprint and eighth in the California market in terms of shelf space. And that's not all, the company has about million dollars of accounts receivable (AR), which is a "phenomenal statistic, given the size of Gold Flora," according to Tom Zuber, a managing partner at Zuber L
As the premier gathering of top entrepreneurs and investors took place on Monday in New Jersey, we thought it would be a good time to scroll through the latest leadership changes in the cannabis and psychedelics industries. Cybin Inc. (NYSE:CYBN) (Cboe CA: CYBN) a clinical-stage biopharmaceutical company that develops new and innovative next-generation psychedelic-based treatment options, announced recently that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, opted to join the company as senior vice president of clinical development. Dr. Mahableshwarkar agreed to lead the development of the CYB003 program, Cybin's proprietary deuterated psilocybin analog which has received U.S. Food and Drug
8-K - Gold Flora Corp. (0001876945) (Filer)
8-K - Gold Flora Corp. (0001876945) (Filer)
10-Q - Gold Flora Corp. (0001876945) (Filer)
COSTA MESA, Calif., Nov. 6, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB:GRAM) today announced that the Court of Chancery of the State of Delaware has granted a stipulation and order, and an interim report (the "Report") has been filed, staying the previously announced temporary appointment of a limited purpose receiver. The appointment was made for the purpose of negotiating a payment plan for law firm fees relating to the matter between two groups of former directors of Left Coast Ventures ("LCV"), a subsidiary of the Company. Pursuant to the Report, the limited receiver stayed the limited receivership, conditioned upon the Company's compl
COSTA MESA, Calif., Nov. 15, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB:GRAM) a leading vertically-integrated California cannabis company, today announced that Mark Castaneda has ended his service as a member of the Board of Directors of Gold Flora, effective November 30, 2024. Mr. Castaneda also served as the Chairman of the Audit Committee of the Board of Directors and a member of the Compensation Committee. "On behalf of the Board and everyone at Gold Flora, we would like to thank Mark for his contributions and dedication
Reports $32.6 Million in Q3 2024 Revenue and Adjusted Gross Profit of $21.1 Million, Representing a 65% Adjusted Gross Margin Achieves Positive Adjusted EBITDA of $2.8 Million Recent Cultivation Investments Delivered 20% Improvement in Q3 2024 Flower Harvest Yields Compared to Q1 2024 Conference Call to be Held November 14, 2024, at 6:00 p.m. (Eastern Time) COSTA MESA, Calif., Nov. 14, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (CBOE: GRAM) (OTCQB:GRAM) a leading vertically-integrated California cannabis company, announced its financial results for the three month period ("Q3 2024"). All amounts are expressed in U.S. dollars.
Capital Infusion to Further Support Growth Initiatives across California COSTA MESA, Calif., Nov. 8, 2024 /CNW/ - Gold Flora Corporation, ("Gold Flora" or the "Company") (Cboe Canada: GRAM) (OTCQB:GRAM) today announced the closing of an additional $2 million draw (the "Additional Draw") on its previously announced, $13.15 million Senior Loan Facility (the "Loan Facility") with J.J. Astor & Co. ("JJ Astor" or "Lender"). To date, the Company has closed on a total of $9.15 million from the Loan Facility, with a further two additional $2.0 million draws available. "This additiona